Genome-wide discovery of hidden genes mediating known drug-disease association

Identifying of hidden genes mediating Known Drug-Disease Association (KDDA) is of great significance for understanding disease pathogenesis and guiding drug repurposing. Here, we present a novel computational tool, called KDDANet, for systematic and accurate uncovering hidden genes mediating KDDA from the perspective of genome-wide gene functional interaction network. By implementing minimum cost flow optimization, combined with depth first searching and graph clustering on a unified flow network model, KDDANet outperforms existing methods in both sensitivity and specificity of identifying genes in mediating KDDA. Case studies on Alzheimer’s disease (AD) and obesity uncover the mechanistic relevance of KDDANet predictions. Furthermore, when applied with multiple types of cancer-omics datasets, KDDANet not only recapitulates known genes mediating KDDAs related to cancer, but also uncovers novel candidates that offer new biological insights. Importantly, KDDANet can be used to discover the shared genes mediating multiple KDDAs. KDDANet can be accessed at http://www.kddanet.cn and the code can be freely downloaded at https://github.com/huayu1111/KDDANet/.

[1]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[2]  J. Flier,et al.  Obesity and insulin resistance. , 2000, The Journal of clinical investigation.

[3]  G. Fischbach,et al.  Neuregulin and ErbB receptor signaling pathways in the nervous system , 2001, Current Opinion in Neurobiology.

[4]  M. Salmivirta,et al.  Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance. , 2001, Diabetes.

[5]  Leena Peltonen,et al.  GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. , 2002, American journal of human genetics.

[6]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[7]  Shailesh V. Date,et al.  A Probabilistic Functional Network of Yeast Genes , 2004, Science.

[8]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[9]  E. Arner,et al.  Adipocyte lipases and defect of lipolysis in human obesity. , 2005, Diabetes.

[10]  B. Sarkadi,et al.  Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[11]  David Bradley,et al.  Why big pharma needs to learn the three 'R's , 2005, Nature Reviews Drug Discovery.

[12]  S. Khan,et al.  Enhancing hepatic glycolysis reduces obesity: differential effects on lipogenesis depend on site of glycolytic modulation. , 2005, Cell metabolism.

[13]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[14]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[15]  H. Ghofrani,et al.  Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond , 2006, Nature Reviews Drug Discovery.

[16]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[17]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[18]  Oliver Gautschi,et al.  Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. , 2007, Lung cancer.

[19]  A. Fraser,et al.  A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans , 2008, Nature Genetics.

[20]  M. Tang,et al.  SPARC in cancer biology: its role in cancer progression and potential for therapy. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[21]  Michael Q. Zhang,et al.  Network-based global inference of human disease genes , 2008, Molecular systems biology.

[22]  A. Hopkins Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[23]  M. Mattson,et al.  Notch: from neural development to neurological disorders , 2008, Journal of neurochemistry.

[24]  Sven Bergmann,et al.  A modular approach for integrative analysis of large-scale gene-expression and drug-response data , 2008, Nature Biotechnology.

[25]  J. Gómez Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer's disease. , 2008, Endocrine, metabolic & immune disorders drug targets.

[26]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[27]  B. Viollet,et al.  Targeting the AMPK pathway for the treatment of Type 2 diabetes. , 2009, Frontiers in bioscience.

[28]  S. Yan,et al.  RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation? , 2009, Journal of Alzheimer's disease : JAD.

[29]  D. Karger,et al.  Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity , 2009, Nature Genetics.

[30]  Thomas C. Wiegers,et al.  Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical–gene–disease networks , 2008, Nucleic Acids Res..

[31]  D. Karger,et al.  Bridging the gap between high-throughput genetic and transcriptional data reveals cellular pathways responding to alpha-synuclein toxicity , 2009 .

[32]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[33]  Tiago Gil Oliveira,et al.  Phospholipase D in brain function and Alzheimer's disease. , 2010, Biochimica et biophysica acta.

[34]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[35]  G. MacQueen,et al.  The Role of Adipokines in Understanding the Associations between Obesity and Depression , 2010, Journal of obesity.

[36]  A. Barabasi,et al.  Interactome Networks and Human Disease , 2011, Cell.

[37]  R. Sharan,et al.  PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.

[38]  E. Marcotte,et al.  Prioritizing candidate disease genes by network-based boosting of genome-wide association data. , 2011, Genome research.

[39]  Xing-Ming Zhao,et al.  Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data , 2011, PLoS Comput. Biol..

[40]  Roded Sharan,et al.  PRINCIPLE: a tool for associating genes with diseases via network propagation , 2011, Bioinform..

[41]  Tao Jiang,et al.  Uncover disease genes by maximizing information flow in the phenome–interactome network , 2011, Bioinform..

[42]  Wei Zhang,et al.  eResponseNet: a package prioritizing candidate disease genes through cellular pathways , 2011, Bioinform..

[43]  E. C. Neto,et al.  Association of adipokines and adhesion molecules with indicators of obesity in women undergoing mammography screening , 2012, Nutrition & Metabolism.

[44]  Paul M. Thompson,et al.  Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression☆ , 2012, NeuroImage.

[45]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[46]  R. Sharan,et al.  INDI: a computational framework for inferring drug interactions and their associated recommendations , 2012, Molecular systems biology.

[47]  Shiwen Zhao,et al.  A co-module approach for elucidating drug-disease associations and revealing their molecular basis , 2012, Bioinform..

[48]  Hua Yu,et al.  A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.

[49]  R. Altman,et al.  Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.

[50]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[51]  F. Santilli,et al.  Platelet activation in obesity and metabolic syndrome , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[52]  Yan Peng,et al.  Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy. , 2013, Pharmacogenomics.

[53]  Andrew M. Gross,et al.  Network-based stratification of tumor mutations , 2013, Nature Methods.

[54]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[55]  P. Sanseau,et al.  Computational Drug Repositioning: From Data to Therapeutics , 2013, Clinical pharmacology and therapeutics.

[56]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[57]  M. Reale,et al.  Cholinergic system dysfunction and neurodegenerative diseases: cause or effect? , 2014, CNS & neurological disorders drug targets.

[58]  Helmut Klocker,et al.  Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis , 2014, Oncotarget.

[59]  L Wang,et al.  Systematic Analysis of New Drug Indications by Drug-Gene-Disease Coherent Subnetworks. , 2014, CPT: pharmacometrics & systems pharmacology.

[60]  C. Evans,et al.  Autophagy as a modulator and target in prostate cancer , 2014, Nature Reviews Urology.

[61]  David S. Wishart,et al.  SMPDB 2.0: Big Improvements to the Small Molecule Pathway Database , 2013, Nucleic Acids Res..

[62]  L. Wang,et al.  Systematic Analysis of New Drug Indications by Drug-Gene-Disease Coherent Subnetworks , 2014, CPT: pharmacometrics & systems pharmacology.

[63]  Yota Otachi,et al.  Depth-First Search Using O(n) Bits , 2014, ISAAC.

[64]  A. Barabasi,et al.  Human symptoms–disease network , 2014, Nature Communications.

[65]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[66]  Andrei G. Vlassenko,et al.  Brain aerobic glycolysis functions and Alzheimer’s disease , 2015, Clinical and Translational Imaging.

[67]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[68]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[69]  Benjamin J. Raphael,et al.  Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.

[70]  Intawat Nookaew,et al.  Proteome- and transcriptome-driven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes. , 2015, Cell reports.

[71]  Núria Queralt-Rosinach,et al.  DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes , 2015, Database J. Biol. Databases Curation.

[72]  A. Summerlee,et al.  Targeting the relaxin hormonal pathway in prostate cancer , 2015, International journal of cancer.

[73]  N. Cordes,et al.  Focal adhesion signaling and therapy resistance in cancer. , 2015, Seminars in cancer biology.

[74]  T. Tammela,et al.  Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population‐based case–control study , 2015, International journal of cancer.

[75]  Hai-hua Luo,et al.  AB044. AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation , 2015, American journal of cancer research.

[76]  Albert-László Barabási,et al.  A DIseAse MOdule Detection (DIAMOnD) Algorithm Derived from a Systematic Analysis of Connectivity Patterns of Disease Proteins in the Human Interactome , 2015, PLoS Comput. Biol..

[77]  S. Salzberg,et al.  StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.

[78]  Avi Ma'ayan,et al.  Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain , 2016, eLife.

[79]  Y. Rabinowitz,et al.  Genetics in Keratoconus: where are we? , 2016, Eye and Vision.

[80]  Emanuel J. V. Gonçalves,et al.  A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.

[81]  Hu Li,et al.  NetDecoder: a network biology platform that decodes context-specific biological networks and gene activities , 2016, Nucleic acids research.

[82]  Shi-Hua Zhang,et al.  Integrative analysis for identifying joint modular patterns of gene-expression and drug-response data , 2016, Bioinform..

[83]  F. Supek,et al.  MUFFINN: cancer gene discovery via network analysis of somatic mutation data , 2016, Genome Biology.

[84]  Intawat Nookaew,et al.  Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes. , 2016, Cell reports.

[85]  A. Barabasi,et al.  Network-based in silico drug efficacy screening , 2016, Nature Communications.

[86]  Susan M. Corley,et al.  RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients , 2018, Scientific Reports.

[87]  Lilin Zheng Plasminogen: a potential target gene for dietary supplements and biomarker of the early stage of obesity by fatigue mice , 2017 .

[88]  T. Cassano,et al.  Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease , 2017, Psychoneuroendocrinology.

[89]  Núria Queralt-Rosinach,et al.  DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..

[90]  A. Poggi,et al.  The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer. , 2017, Cancer letters.

[91]  Yongshuai Jiang,et al.  Genome-wide pathway-based association analysis identifies risk pathways associated with Parkinson’s disease , 2017, Neuroscience.

[92]  Jian Peng,et al.  A Network Integration Approach for Drug-Target Interaction Prediction and Computational Drug Repositioning from Heterogeneous Information , 2017, RECOMB 2017.

[93]  Jian Peng,et al.  A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information , 2017, Nature Communications.

[94]  Justyna A. Karolak,et al.  Collagen synthesis disruption and downregulation of core elements of TGF-β, Hippo, and Wnt pathways in keratoconus corneas , 2017, European Journal of Human Genetics.

[95]  Kexin Shen,et al.  SUMO-1 Gene Silencing Inhibits Proliferation and Promotes Apoptosis of Human Gastric Cancer SGC-7901 Cells , 2017, Cellular Physiology and Biochemistry.

[96]  Benjamin J. Raphael,et al.  Network propagation: a universal amplifier of genetic associations , 2017, Nature Reviews Genetics.

[97]  Jens Nielsen,et al.  Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes , 2017, Genome Medicine.

[98]  Albert-László Barabási,et al.  Network-based approach to prediction and population-based validation of in silico drug repurposing , 2018, Nature Communications.

[99]  M. Passafaro,et al.  Glutamatergic synapses in neurodevelopmental disorders , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[100]  Nasser Ghadiri,et al.  A review of network‐based approaches to drug repositioning , 2018, Briefings Bioinform..

[101]  Lu Lu,et al.  DR2DI: a powerful computational tool for predicting novel drug-disease associations , 2018, Journal of Computer-Aided Molecular Design.

[102]  Ravi Iyengar,et al.  The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. , 2017, Cell systems.

[103]  Mariko Sawa,et al.  Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome. , 2018, Free radical biology & medicine.

[104]  F. Huang,et al.  δ-Catenin promotes tumorigenesis and metastasis of lung adenocarcinoma. , 2017, Oncology reports.

[105]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[106]  B. Ogretmen,et al.  Sphingolipid metabolism in cancer signalling and therapy , 2017, Nature Reviews Cancer.

[107]  Ashton C. Berger,et al.  Author Correction: Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells , 2018, Nature Communications.

[108]  M. Gearing,et al.  Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer’s disease , 2018, Acta neuropathologica communications.

[109]  Fengshan Wang,et al.  The Role of Grb2 in Cancer and Peptides as Grb2 Antagonists. , 2017, Protein and peptide letters.

[110]  W. Swardfager,et al.  The complement cascade in Alzheimer’s disease: a systematic review and meta-analysis , 2019, Molecular Psychiatry.

[111]  Ping Xuan,et al.  Drug repositioning through integration of prior knowledge and projections of drugs and diseases , 2019, Bioinform..

[112]  Salvatore Alaimo,et al.  Network-Based Drug Repositioning: Approaches, Resources, and Research Directions. , 2018, Methods in molecular biology.

[113]  R. Mailman,et al.  Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[114]  Albert-László Barabási,et al.  Network-based prediction of drug combinations , 2019, Nature Communications.

[115]  Isobel S Okoye,et al.  E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[116]  F. Caramia,et al.  The Relationships Between Vitamin K and Cognition: A Review of Current Evidence , 2019, Front. Neurol..

[117]  A. Carrier,et al.  PML hyposumoylation is responsible for the resistance of pancreatic cancer , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[118]  A. Halle,et al.  Inhibition of Stat3‐mediated astrogliosis ameliorates pathology in an Alzheimer's disease model , 2019, EMBO molecular medicine.

[119]  Joshua M. Korn,et al.  Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.

[120]  Hua Yu,et al.  Systematic discovery of novel and valuable plant gene modules by large‐scale RNA‐seq samples , 2018, Bioinform..

[121]  Fatemeh Zare-Mirakabad,et al.  The assessment of efficient representation of drug features using deep learning for drug repositioning , 2019, BMC Bioinformatics.

[122]  F. Sanz,et al.  The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..

[123]  Guiyou Liu,et al.  Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study. , 2020, Journal of Alzheimer's disease : JAD.

[124]  Jianzhu Ma,et al.  Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells. , 2020, Cancer cell.

[125]  Hye-Sun Kim,et al.  Inhibition of STAT3 phosphorylation attenuates impairments in learning and memory in 5XFAD mice, an animal model of Alzheimer's disease. , 2020, Journal of pharmacological sciences.